NCT05292664 2026-03-12Venetoclax Basket Trial for High Risk Hematologic MalignanciesDana-Farber Cancer InstitutePhase 1 Recruiting30 enrolled
NCT05146739 2025-11-12Highest Dose of Uproleselan in Combination With Fludarabine and Cytarabine for Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Mixed Phenotype Acute Leukemia Relapsed or Refractory That Expresses E-selectin Ligand on the Cell MembraneNational Cancer Institute (NCI)Phase 1 Active not recruiting8 enrolled
NCT00003331 2011-03-28Combination Chemotherapy in Treating Patients With Advanced CancerNYU Langone HealthPhase 1 Completed30 enrolled